The typical immunophenotype of APL, including MPO+/HLA‐DR‐/CD34‐ and CD117+, provided a sensitivity of 51.4%, a specificity of 98.0%, a positive predictive value of 65.8%, and a negative predictive value of 96.5%. This evidence concerns the gene MPO and acute promyelocytic leukemia.